U.S. stock futures soar on positive results from Moderna vaccine trial, assurances of Fed support
MONDAY, MAY 18, 2020
U.S. markets were poised for recovery Monday as good news out of Moderna's coronavirus vaccine trials spurred optimism in investors, with Dow futures calling for a more than 650-point, or 2.7%, jump at opening bell.